CIK 0000072444 · Accelerated filer<br>Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 591212264
- Phone
- (650) 550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
- DEFC14A Other DEFC14A
- PRRN14A Other PRRN14A
- PREC14A Other PREC14A
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- ARS Other Annual Report to Security Holders
- EFFECT Other Notice of Effectiveness
Page 5 of 12 · 235 filings